(Q38059247)

28 August 2017

Role of fetuin-A in atherosclerosis associated with diabetic patients (English)

1 reference

28 August 2017

1 reference

Monika Singh

1

1 reference

28 August 2017

Pramod Kumar Sharma

2

1 reference

28 August 2017

Vipin Kumar Garg

3

1 reference

28 August 2017

Shambhu Charan Mondal

4

1 reference

28 August 2017

Avnesh Kumar Singh

5

1 reference

28 August 2017

Nikhlesh Kumar

6

1 reference

28 August 2017

4 July 2012

1 reference

Journal of Pharmacy and Pharmacology

28 August 2017

1 reference

28 August 2017

64

1 reference

28 August 2017

12

1 reference

28 August 2017

1703-1708

1 reference

Fetuin-A and incident diabetes mellitus in older persons

28 August 2017

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

alpha2HS-glycoprotein, an antagonist of transforming growth factor beta in vivo, inhibits intestinal tumor progression

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

α2-HS Glycoprotein/Fetuin, a Transforming Growth Factor-β/Bone Morphogenetic Protein Antagonist, Regulates Postnatal Bone Growth and Remodeling

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Emerging role for fetuin-A as contributor to morbidity and mortality in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

The serum protein alpha 2-Heremans-Schmid glycoprotein/fetuin-A is a systemically acting inhibitor of ectopic calcification

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Alpha2-Heremans-Schmid glycoprotein/fetuin-A is associated with insulin resistance and fat accumulation in the liver in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Human serum fetuin A/alpha2HS-glycoprotein level is associated with long-term survival in patients with alcoholic liver cirrhosis, comparison with the Child-Pugh and MELD scores

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Xenopus cDNA microarray identification of genes with endodermal organ expression.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Fetuin-B, a second member of the fetuin family in mammals

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Haplotype analysis of the human alpha2-HS glycoprotein (fetuin) gene

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Decreased levels of circulating alpha2-Heremans-Schmid glycoprotein/Fetuin-A (AHSG) in patients with rheumatoid arthritis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Fetuin-A induces cytokine expression and suppresses adiponectin production

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Fetuin-A and its relation to metabolic syndrome and fatty liver disease in obese children before and after weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Elevated Fetuin-A concentrations in morbid obesity decrease after dramatic weight loss

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Association of low fetuin-A (AHSG) concentrations in serum with cardiovascular mortality in patients on dialysis: a cross-sectional study

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Diabetic nephropathy: diagnosis, prevention, and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

The role of epigenetics in the pathology of diabetic complications

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Serum fetuin-A is correlated with metabolic syndrome in middle-aged and elderly Chinese

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Serum fetuin-A is an independent marker of insulin resistance in Japanese men.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

The nucleotide and partial amino acid sequences of rat fetuin. Identity with the natural tyrosine kinase inhibitor of the rat insulin receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Genetic mapping and functional studies of a natural inhibitor of the insulin receptor tyrosine kinase: the mouse ortholog of human alpha2-HS glycoprotein

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Critical nodes in signalling pathways: insights into insulin action

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Fetuin-null mice are protected against obesity and insulin resistance associated with aging.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Vascular calcification: the three-hit model

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Fetuin-A is an independent predictor of death after ST-elevation myocardial infarction.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Plasma fetuin-A levels and the risk of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Plasma fetuin-a levels and the risk of myocardial infarction and ischemic stroke

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Association of the T-G polymorphism in adiponectin (exon 2) with obesity and insulin sensitivity: interaction with family history of type 2 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Chronic kidney disease-related atherosclerosis - proteomic studies of blood plasma

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Mitral and aortic annular calcification are highly associated with systemic calcified atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Telomere attrition is associated with inflammation, low fetuin-A levels and high mortality in prevalent haemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Atherosclerosis in chronic kidney disease: the role of macrophages

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

How hyperglycemia promotes atherosclerosis: molecular mechanisms

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Association of serum fetuin-A with carotid arterial stiffness.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Cardiac calcifications: Fetuin-A and other risk factors in hemodialysis patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Vascular calcification and fetuin-A deficiency in chronic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

C-reactive protein and other circulating markers of inflammation in the prediction of coronary heart disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Diabetes and atherosclerosis: epidemiology, pathophysiology, and management

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: Part I.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Protective role of α2HS-glycoprotein in HBV-associated liver failure

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

Low fetuin-A levels are associated with cardiovascular death: Impact of variations in the gene encoding fetuin

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.2042-7158.2012.01561.X

10.1111/J.2042-7158.2012.01561.X

21 January 2018

Identifiers

DOI

1 reference

28 August 2017

1 reference